(MENAFN- GlobeNewsWire - Nasdaq) San Francisco, CA, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Java World Mag is issuing this follow-up report to provide additional factual and legal context regarding its ...
Good day, and thank you for standing by. Welcome to the Structure Therapeutics top line results from the aleniglipron Phase II Access Program. [Operator Instructions] Please be advised that today's ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
Parents, you're going to need a bigger piggy bank. An announcement by Michael and Susan Dell that they will donate more than $6 billion in the form of contributions to soon-to-be-opened Trump accounts ...
The Air Force is yanking most of its biggest programs out from its existing program-management structure and putting them under a new four-star who reports to the deputy defense secretary. On Tuesday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results